MEDizzy
MEDizzy
Amy Kosran
Amy Kosran4 months ago
ADC With Radiotherapy for Brain Mets Ups Risk of Necrosis

ADC With Radiotherapy for Brain Mets Ups Risk of Necrosis

An antibody-drug conjugate given concurrently with stereotactic radiotherapy to treat brain metastases may increase patients' risk for symptomatic radiation necrosis, a study suggests.

Source: https://www.medscape.com/viewarticle/998023?src=mbl_msp_android&ref=share
1
Other commentsSign in to post comments. You don't have an account? Sign up now!

Recent MCQs















Show more MCQs

Recent flashcard sets















Show more flashcards